Fundamental Analysis of OBSEVA SA(NASDAQ:OBSV) stock

Fundamental Rating

Taking everything into account, OBSV scores 1 out of 10 in our fundamental rating. OBSV was compared to 588 industry peers in the Biotechnology industry. Both the profitability and financial health of OBSV have multiple concerns. OBSV is quite expensive at the moment. It does show a decent growth rate.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year OBSV has reported negative net income.

OBSV had a negative operating cash flow in the past year.

OBSV had negative earnings in each of the past 5 years.

In the past 5 years OBSV always reported negative operating cash flow.

1.2 Ratios

OBSV has negative profitability rations, so we won't be analyzing them here.

		Industry Rank	Sector Rank
ROA	N/A
ROE	N/A
ROIC	N/A

ROA(3y)N/A

ROA(5y)N/A

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

OBSV does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	N/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

OBSV does not have a ROIC to compare to the WACC, probably because it is not profitable.

Compared to 1 year ago, OBSV has more shares outstanding

Compared to 1 year ago, OBSV has an improved debt to assets ratio.

2.2 Solvency

OBSV has an Altman-Z score of -45.57. This is a bad value and indicates that OBSV is not financially healthy and even has some risk of bankruptcy.

OBSV has a Altman-Z score of -45.57. This is amonst the worse of the industry: OBSV underperforms 91.76% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	N/A
Debt/FCF	N/A
Altman-Z	-45.57

ROIC/WACCN/A

WACC8.72%

2.3 Liquidity

A Current Ratio of 0.61 indicates that OBSV may have some problems paying its short term obligations.

Looking at the Current ratio, with a value of 0.61, OBSV is doing worse than 91.76% of the companies in the same industry.

A Quick Ratio of 0.61 indicates that OBSV may have some problems paying its short term obligations.

The Quick ratio of OBSV (0.61) is worse than 91.28% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	0.61
Quick Ratio	0.61

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 6.94% over the past year.

The Revenue for OBSV has decreased by -57.43% in the past year. This is quite bad

Measured over the past years, OBSV shows a very strong growth in Revenue. The Revenue has been growing by 298.56% on average per year.

EPS 1Y (TTM)6.94%

EPS 3YN/A

EPS 5YN/A

EPS growth Q2Q-110%

Revenue 1Y (TTM)-57.43%

Revenue growth 3Y901.88%

Revenue growth 5Y298.56%

Revenue growth Q2Q-81.53%

3.2 Future

The Earnings Per Share is expected to grow by 26.26% on average over the next years. This is a very strong growth

OBSV is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 11.07% yearly.

EPS Next Y12.85%

EPS Next 2Y32.71%

EPS Next 3Y26.26%

EPS Next 5YN/A

Revenue Next Year-33.03%

Revenue Next 2Y-41.42%

Revenue Next 3Y14.26%

Revenue Next 5Y11.07%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

OBSV reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

Also next year OBSV is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

OBSV's earnings are expected to grow with 26.26% in the coming years. This may justify a more expensive valuation.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y32.71%

EPS Next 3Y26.26%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

OBSV does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

OBSEVA SA

NASDAQ:OBSV (3/22/2023, 8:20:53 PM)

After market: 0.0826 -0.02 (-18.86%)

0.1018

-0.02 (-15.52%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences

GICS IndustryBiotechnology

Earnings (Last)

Earnings (Next)

Inst Owners

Inst Owner Change

Ins Owners

Ins Owner Change

Market Cap8.60M

Analysts

Price Target

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Dividend Growth(5Y)

Div Incr Years

Div Non Decr Years

Ex-Date

Surprises & Revisions

EPS beat(2)

Avg EPS beat(2)

Min EPS beat(2)

Max EPS beat(2)

EPS beat(4)

Avg EPS beat(4)

Min EPS beat(4)

Max EPS beat(4)

EPS beat(8)

Avg EPS beat(8)

EPS beat(12)

Avg EPS beat(12)

EPS beat(16)

Avg EPS beat(16)

Revenue beat(2)

Avg Revenue beat(2)

Min Revenue beat(2)

Max Revenue beat(2)

Revenue beat(4)

Avg Revenue beat(4)

Min Revenue beat(4)

Max Revenue beat(4)

Revenue beat(8)

Avg Revenue beat(8)

Revenue beat(12)

Avg Revenue beat(12)

Revenue beat(16)

Avg Revenue beat(16)

PT rev (1m)

PT rev (3m)

EPS NQ rev (1m)

EPS NQ rev (3m)

EPS NY rev (1m)

EPS NY rev (3m)

Revenue NQ rev (1m)

Revenue NQ rev (3m)

Revenue NY rev (1m)

Revenue NY rev (3m)

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA

EPS(TTM)

EPS(NY)

Fwd EY

FCF(TTM)

FCFY

OCF(TTM)

OCFY

SpS

BVpS

TBVpS

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	N/A
ROE	N/A
ROCE
ROIC
ROICexc
ROICexgc
OM	N/A
PM (TTM)	N/A
GM	N/A
FCFM

ROA(3y)

ROA(5y)

ROE(3y)

ROE(5y)

ROIC(3y)

ROIC(5y)

ROICexc(3y)

ROICexc(5y)

ROICexgc(3y)

ROICexgc(5y)

ROCE(3y)

ROCE(5y)

ROICexcg growth 3Y

ROICexcg growth 5Y

ROICexc growth 3Y

ROICexc growth 5Y

OM growth 3Y

OM growth 5Y

PM growth 3Y

PM growth 5Y

GM growth 3Y

GM growth 5Y

F-Score

Asset Turnover0.51

Health

		Industry Rank	Sector Rank
Debt/Equity	N/A
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio	0.61
Quick Ratio	0.61
Altman-Z

F-Score

WACC

ROIC/WACC

Cap/Depr(3y)

Cap/Depr(5y)

Cap/Sales(3y)

Cap/Sales(5y)

Profit Quality(3y)

Profit Quality(5y)

Growth

EPS 1Y (TTM)6.94%

EPS 3YN/A

EPS 5Y

EPS growth Q2Q

EPS Next Y12.85%

EPS Next 2Y

EPS Next 3Y

EPS Next 5Y

Revenue 1Y (TTM)-57.43%

Revenue growth 3Y901.88%

Revenue growth 5Y

Revenue growth Q2Q

Revenue Next Year

Revenue Next 2Y

Revenue Next 3Y

Revenue Next 5Y

EBIT growth 1Y

EBIT growth 3Y

EBIT growth 5Y

EBIT Next Year

EBIT Next 3Y

EBIT Next 5Y

FCF growth 1Y

FCF growth 3Y

FCF growth 5Y

OCF growth 1Y

OCF growth 3Y

OCF growth 5Y

OBSEVA SA (OBSV)

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens